… treatment strategies have become essential in preventing end-stage renal disease … -nephropathy-treatment-market … drug approvals. Previously, treatment options were limited to supportive care, including immunosuppressive drugs … enhance treatment accessibility …

… for certain patients with end-stage renal disease. Kidney transplantation is preferred … a range of control treatment options. The efficacy … imlifidase and a control treatment, Philipson explained. Patients … endpoint. Hansa’s drug was well tolerated and …

… patients were included in each treatment group.1 Finerenone was associated … cohort included 1910 patients.2 Treatment with nsMRAs was associated with … admissions, end-stage heart failure, end-stage renal disease, or dialysis dependence.2 “The …

… failure, also called end-stage renal disease, develops. About 1 … improve your outlook. Treatment response: Medications that control blood … the disease progresses to end-stage renal disease, symptoms may include: … its progression. Other treatments: In some cases, …

… certain beneficiaries, including those with end-stage renal disease, substance use disorder, and … for diagnosis, evaluation, or treatment of a behavioral health … Medicare beneficiaries seeking treatment for behavioral health treatment, compounding challenges …

… depression that requires treatment, wrote researchers … with CKD and end-stage renal disease (ESRD). These authors identified … incident depression requiring treatment: a retrospective cohort … Kidney Disease and End-Stage Renal Disease: Similarities and …

… effects of pharmacological treatments on these patients … and have vasoactive drugs ready. Rare cardiovascular … 113 patients with end-stage renal disease undergoing kidney … Meanwhile, targeted emergency medications (eg, dantrolene, antihistamines …

… kidney impairment to end-stage renal disease often occurs silently, … where costs arise from medication, routine monitoring, potential … the use of medications specifically designed to … treatment plans. This collaborative approach enhances adherence to medication …

… vascular access conduit in hemodialysis treatment. The aXess EU pivotal trial … looked at adult patients with end-stage renal disease requiring vascular access to start … future of hemodialysis vascular access treatment. After this clear demonstration of …

… company focused on transforming treatments for critically ill … chronic kidney disease or end-stage renal disease (ESRD) requiring dialysis. Extreme … focused on transforming treatments for critically ill … U.S. Food and Drug Administration (FDA). QUELIMMUNE …